Shilpa Medicare Limited (NSE: SHILPAMED) acquires 30.4% stake in Gate2Brain to advance brain cancer therapy.
Supriya Lifescience Limited (SUPRIYA) reports a 50% YoY revenue surge in Q4 FY26, driven by strong performance across therapeutic segments.
Blue Jet Healthcare Limited (BLUEJET) reported a 22% QoQ increase in revenue for Q4 FY26, with PAT rising by 60%.
Zota Health Care Limited (ZOTA) reports strong FY26 results with revenue up 83.86% YoY, EBITDA at ₹2,597.73 lakhs, and expansion to 2,579 stores.
Take Solutions Limited (NSE: TAKE) reports a strong financial performance for FY26 with ₹6,087 Lakhs consolidated total income.
Glenmark Pharmaceuticals Limited announces new development candidate ISB 2301, a first-in-class multispecific immune cells activator targeting solid tumors.
Dishman Carbogen Amcis Limited (DCAL) reports a 18.9% revenue increase in Q4 FY26, driven by growth in CDMO and Marketable Molecules segments.
Anthem Biosciences Limited (NSE: ANTHEM) announced its Q4 FY26 results with a 26% YoY revenue growth and a 129.8% surge in PAT.
Zota Health Care Limited (ZOTA) announces brand expansion with Mr. Akshay Kumar as brand ambassador for UGO Generic, enhancing national presence.